[1]史梦蓉,张念志,褚文丰,等.基于“少火生气,壮火食气”探讨肺癌病机及治疗[J].陕西中医,2024,(8):1096-1100.[doi:DOI:10.3969/j.issn.1000-7369.2024.08.019]
　SHI Mengrong,ZHANG Nianzhi,CHU Wenfeng,et al.Exploring the pathogenesis and treatment of lung cancer based on “mild fire generating qi and sthenic fire consuming qi”[J].,2024,(8):1096-1100.[doi:DOI:10.3969/j.issn.1000-7369.2024.08.019]
点击复制

基于“少火生气,壮火食气”探讨肺癌病机及治疗
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年8期
页码:
1096-1100
栏目:
学术探讨
出版日期:
2024-08-05

文章信息/Info

Title:
Exploring the pathogenesis and treatment of lung cancer based on “mild fire generating qi and sthenic fire consuming qi”
作者:
史梦蓉1; 张念志2; 褚文丰1; 金纯纯1
(1.安徽中医药大学第一临床医学院,安徽 合肥 230012; 2.安徽中医药大学第一附属医院,安徽 合肥 230031)
Author(s):
SHI Mengrong; ZHANG Nianzhi; CHU Wenfeng; JIN Chunchun
(First Clinical Medical College of Anhui University of Chinese Medicine,Hefei 230012,China)
关键词:
肺癌;  少火生气;  壮火食气;  病机;  培少火;  清壮火
Keywords:
Lung cancer;  Mild fire generating qi;  Sthenic fire consuming qi;  Pathogenesis;  Cultivating mild fire;  Clearing sthenic fire
分类号:
R 734.2
DOI:
DOI:10.3969/j.issn.1000-7369.2024.08.019
文献标志码:
A
摘要:
肺癌的发病率和死亡率居于我国恶性肿瘤之首,其预后不佳。基于“少火生气,壮火食气”理论,将古代医家记载与现代医学研究结合,明确“少火”“壮火”内涵,气与火两者关系,从“少火生气,壮火食气”切入到肺癌的发病机制,指出“少火衰”是其病机的本质,“少火”不行,正气渐虚,“壮火盛”是其病机的关键,痰热瘀毒内生,虚实兼夹,气火失调,“食气”为表象,贯穿病程始终。从病机探讨中得出治疗思路,“培少火,清壮火,防传变”是论治肺癌的核心,包含三方面:益气温阳,培土生金以助少火生气; 泻火解毒,凉血养阴以平壮火食气; 消痰散结,祛瘀生新,谨防变证。
Abstract:
Lung cancer has the highest incidence rate and mortality among malignant tumors in China,and its prognosis is poor.Based on the theory of “mild fire generating qi and sthenic fire consuming qi”,combining ancient medical records with modern medical research,clarifying the connotations of “mild fire” and “sthenic fire”,as well as the relationship between qi and fire,and starting from “mild fire generating qi and sthenic fire consuming qi” to explore the pathogenesis of lung cancer.It is pointed out that “mild fire” is the essence of its pathogenesis,“sthenic fire” is the key to its pathogenesis.Phlegm,heat,stasis,and toxins are generated in the body,resulting in a combination of deficiency and excess,as well as an imbalance of qi and fire.“Consuming qi” is the surface manifestation that runs through the entire course of the disease.From the exploration of the pathogenesis,the treatment approach is derived.“Cultivating mild fire,clearing sthenic fire,and preventing transmission” is the core of the treatment of lung cancer,which includes three aspects.Nourishing qi and warming yang,cultivating soil and generating gold to help mild fire consuming qi.Purge fire and detoxify,cool blood and nourish yin to eliminate sthenic fire consuming qi.Dispelling phlegm and nodules,removing blood stasis and generating new vitality,and guarding against changes in symptoms.

参考文献/References:

[1] 由金玲,徐晓慧,林琳,等.基于GBD数据分析1990年和2019年中国人群癌谱差异[J].中国肿瘤,2024,33(1):36-43.
[2] 张景暄,付庭吕,李宁,等.《肺癌的全球负担:当前状态和未来趋势》要点解读[J].中国胸心血管外科临床杂志,2024,31(1):17-23.
[3] 苏颖.内经选读[M].北京:高等教育出版社,2015:45.
[4] 王冰.重广补注黄帝内经素问[M].北京:学苑出版社,2014:106.
[5] 王苏晋,蒋鹭莲,徐晓华,等.基于“气火学说”及线粒体能量代谢机制论治肺癌[J].中医学报,2023,38(5):932-936.
[6] 陈丽娟,文颖娟,仝武宁.基于“线粒体动力学”机制探讨糖尿病心肌病“壮火食气”的科学内涵[J].湖南中医药大学学报,2022,42(5):820-824.
[7] 张嘉琦,黎晓冬,邱静,等.谢学军教授基于“少火生气、壮火食气”理论辨治非感染性葡萄膜炎经验[J].四川中医,2023,41(11):4-7.
[8] 孙靖茹,贾新华.基于“壮火食气,少火生气”论激素依赖型哮喘的中西医诊治[J].山东中医杂志,2023,42(8):791-797.
[9] 罗成,叶远航,柯佳.从“壮火食气”探讨炎症对肺癌的影响[J].中医学报,2024,39(4):689-694.
[10] 郭家毓,呼群.小细胞肺癌免疫治疗研究进展[J].陕西医学杂志,2023,52(1):118-121.
[11] GENOVA C,DELLEPIANE C,CARREGA P,et al.Therapeutic implications of tumor microenvironment in lung cancer:Focus on immune checkpoint blockade[J].Front Immunol,2022,12:799455.
[12] 姜彧,孙磊涛,沈敏鹤,等.基于《黄帝内经》“壮火”理论探讨癌毒性质[J].北京中医药大学学报,2022,45(5):478-482.
[13] 杨巧丽,郑好飞,刘颖.“壮火食气,少火生气”对“火”病和“气”病的指导意义[J].中医学报,2020,35(12):2514-2517.
[14] 戴义宁,李慧杰,李秀荣.基于“痞坚之处,必有伏阳”探讨肿瘤微环境的形成与干预[J].中医杂志,2023,64(22):2275-2281.
[15] 黄文博,潘丽,黄娅,等.基于能量代谢重编程论“阴火”与中医肿瘤发生学[J].中医杂志,2022,63(10):905-909.
[16] 杨芙蓉,张雨婷,陈志鹏,等.肿瘤代谢介导的免疫逃逸及血管生成研究进展[J].中国药理学通报,2021,37(6):756-760.
[17] 温丹婷,周慧萍.基于癌毒理论对肿瘤微环境的中医认识[J].实用医学杂志,2023,39(19):2556-2560.
[18] 朱紫衣,刘晨霞,江忠勇,等.肿瘤细胞线粒体靶向治疗机制及药物研究进展[J].陕西医学杂志,2021,50(9):1170-1173.
[19] 陈少昀,马纯政,程新月,等.中性粒细胞胞外诱捕网与肺“炎-癌”转化及肺癌之间相关性的研究进展[J].肿瘤学杂志,2023,29(5):380-385.
[20] 张传龙,姜晓晨,庞博,等.基于“热极成毒”理论探讨肺“炎-癌转化”与防治思路[J].北京中医药大学学报,2022,45(3):291-295.
[21] 贺佳文,韩冰,卢佳萱,等.基于“虚气留滞”理论探讨肺癌高凝状态的病机与治法[J].北京中医药大学学报,2023,46(12):1767-1771.
[22] 张尤,陈炜.名中医韩明向基于“一本四证”论治肺癌经验[J].陕西中医,2023,44(12):1788-1791.
[23] 韩欣璞,许博文,李杰.基于“寒气生浊”探讨胃癌微环境的微观辨治[J].中医杂志,2022,63(12):1135-1138.
[24] 刘小雄,曹邦卿,吕伟,等.补中益气汤联合放化疗对肺癌术后患者免疫功能及生活质量的影响[J].中国医学创新,2023,20(27):88-92.
[25] 聂冬辉,刘振昌,董金伟,等.六君子汤加减对老年中晚期肺癌化疗患者免疫功能的保护作用[J].西部中医药,2022,35(8):97-100.
[26] 花宝金,庞博,朴炳奎.中医药防治肺癌的优势与策略[J].北京中医药,2022,41(5):472-475.
[27] 张茂福,张志明,宋忠阳,等.中医药靶向Wnt/β-catenin信号通路防治肺癌的研究进展[J].中国实验方剂学杂志,2024,30(8):262-270.
[28] 刘晓琳,李毅平,林柳兵,等.中医药干预肿瘤炎性微环境研究进展[J].现代中西医结合杂志,2023,32(1):138-141,146.
[29] 郗昱檀,马纯政,常思思,等.基于数据挖掘分析全国名老中医治疗肺癌经验及用药规律[J].辽宁中医杂志,2022,49(12):1-5.
[30] 高尚,李巾,黄费炳,等.沙参麦冬汤的药理作用和临床应用研究进展[J].中医药导报,2020,26(2):115-118,123.
[31] 杨晓慧,臧海洋,顾小侠,等.麦门冬汤基于调节肿瘤相关巨噬细胞表型抑制肺癌增殖转移的机制研究[J].辽宁中医杂志,2022,49(9):148-151,224.
[32] 钟佳,刘华,王理槐.基于“癌毒传舍”理论防治肺癌转移[J].湖南中医药大学学报,2021,41(12):1950-1953.
[33] 孙睿博,韩钦芮,徐萌,等.肿瘤转移前龛环境的正虚痰瘀病机探讨[J].中华中医药杂志,2021,36(6):3529-3532.
[34] 宁永波,王雅兴,陈香颖,等.名中医王瑞平“期证相合”理论在肺癌术后研究肿瘤微环境经验[J].陕西中医,2023,44(10):1448-1451.
[35] 高红果,魏娜.生脉饮合血府逐瘀汤对NSCLC患者血液高凝状态的影响[J].深圳中西医结合杂志,2022,32(10):35-38.
[36] 倪子惠,曹可馨,刘晓,等.大黄虫丸抗癌作用的基础理论及临床治疗研究进展[J].中国中医基础医学杂志,2019,25(5):710-714.

相似文献/References:

[1]刘海涛 ,衣秀秀,田建辉△.肺癌中西医抗凝治疗研究进展*[J].陕西中医,2020,(1):127.
[2]邵翠丽,周晋华△,杨勤军,等.周晋华运用环磷酰胺联合中药紫杉治疗晚期肺癌经验*[J].陕西中医,2020,(2):223.
　SHAO Cuili,ZHOU Jinhua,YANG Qinjun,et al.ZHOU Jinhua treats advanced lung cancer with cyclophosphamide and purple shirt[J].,2020,(8):223.
[3]汪 莉,杜红旭,周正国,等.攻癌固真汤联合吉非替尼治疗肺癌气虚血瘀证疗效及对患者血流状态的影响[J].陕西中医,2021,(3):338.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.017]
　WANG Li,DU Hongxu,ZHOU Zhengguo,et al.Clinical effect of Gong'ai Guzhen decoction combined with gefitinib in treating lung cancer with Qixu Xueyu syndrome and affect blood flow state[J].,2021,(8):338.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.017]
[4]汪宗清,陈 晨,侯 卫,等.基于“少火生气,壮火食气”理论治疗硬皮病[J].陕西中医,2021,(4):499.[doi:DOI:10.3969/j.issn.1000-7369.2020.04.025]
　WANG Zongqing,CHEN Chen,HOU Wei,et al.Treating scleroderma based on the theory of “Mild Fire supplements qi,Strong fire reduces qi”[J].,2021,(8):499.[doi:DOI:10.3969/j.issn.1000-7369.2020.04.025]
[5]郑 茜,刘远婷,丁甜甜,等.消积抑癌方对Lewis肺癌荷瘤小鼠MMP-2的影响[J].陕西中医,2021,(7):844.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.007]
　ZHENG Qian,LIU Yuanting,DING Tiantian,et al.Effect of Xiaoji Yi'ai recipe on MMP-2 in Lewis lung cancer bearing mice[J].,2021,(8):844.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.007]
[6]刘文佳,刘宗凯,初晓苏,等.山慈菇-王不留行干预肺癌向骨转移过程生物信息学作用机制[J].陕西中医,2021,(9):1302.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.041]
[7]杨 昕,李和根.肺癌辨证分型研究进展[J].陕西中医,2021,(9):1313.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.043]
　YANG Xin,LI Hegen.Progress in syndrome differentiation of lung cancer[J].,2021,(8):1313.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.043]
[8]李 健,贾 瑞,王 超,等.健脾益气汤联合化疗对肺癌术后患者免疫功能的影响[J].陕西中医,2023,(4):459.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.011]
　LI Jian,JIA Rui,WANG Chao,et al.Effect of Jianpi Yiqi decoction combined with chemotherapy on immune function in patients with lung cancer after surgery[J].,2023,(8):459.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.011]
[9]宁永波,王雅兴,陈香颖,等.名中医王瑞平“期证相合”理论在肺癌术后研究肿瘤微环境经验[J].陕西中医,2023,(10):1448.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.026]
　NING Yongbo,WANG Yaxing,CHEN Xiangying,et al.Wang Ruiping's theory of “phase correspondence” in postoperative lung cancer patients[J].,2023,(8):1448.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.026]
[10]张 尤,陈 炜.名中医韩明向基于“一本四证”论治肺癌经验[J].陕西中医,2023,(12):1788.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.027]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助面上项目(82174312); 安徽省中医肺病临床医学研究中心项目[皖科社(2020)41号]; 安徽省中医药领军人才项目[安徽省卫生和计划生育委员会中医药发展秘(2018)23号]
更新日期/Last Update: 2024-08-08